- Home
- GFI vs ONC Comparison
GFI vs ONC Comparison
Compare GFI & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFI
- ONC
- Stock Information
- Founded
- GFI 1887
- ONC 2010
- Country
- GFI South Africa
- ONC Switzerland
- Employees
- GFI N/A
- ONC N/A
- Industry
- GFI Precious Metals
- ONC Biotechnology: Pharmaceutical Preparations
- Sector
- GFI Basic Materials
- ONC Health Care
- Exchange
- GFI Nasdaq
- ONC Nasdaq
- Market Cap
- GFI 37.6B
- ONC 37.3B
- IPO Year
- GFI 2007
- ONC N/A
- Fundamental
- Price
- GFI $41.83
- ONC $341.63
- Analyst Decision
- GFI Hold
- ONC Strong Buy
- Analyst Count
- GFI 5
- ONC 10
- Target Price
- GFI $25.62
- ONC $340.70
- AVG Volume (30 Days)
- GFI 3.5M
- ONC 273.8K
- Earning Date
- GFI 08-22-2025
- ONC 11-11-2025
- Dividend Yield
- GFI 1.51%
- ONC N/A
- EPS Growth
- GFI 198.42
- ONC N/A
- EPS
- GFI 2.08
- ONC N/A
- Revenue
- GFI $6,555,200,000.00
- ONC $4,562,002,000.00
- Revenue This Year
- GFI $55.14
- ONC $881.07
- Revenue Next Year
- GFI $14.86
- ONC N/A
- P/E Ratio
- GFI $20.27
- ONC N/A
- Revenue Growth
- GFI 50.41
- ONC 47.33
- 52 Week Low
- GFI $12.98
- ONC $170.99
- 52 Week High
- GFI $43.13
- ONC $355.30
- Technical
- Relative Strength Index (RSI)
- GFI 65.72
- ONC 58.55
- Support Level
- GFI $40.55
- ONC $334.53
- Resistance Level
- GFI $42.93
- ONC $355.30
- Average True Range (ATR)
- GFI 1.43
- ONC 7.35
- MACD
- GFI -0.18
- ONC -0.08
- Stochastic Oscillator
- GFI 78.55
- ONC 60.50
About GFI Gold Fields Limited
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.